Published in Int Immunol on January 01, 1990
Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet (1998) 1.33
Effect of different sensitizing doses of antigen in a murine model of atopic asthma. Clin Exp Immunol (1999) 0.92
Transgenic mice in the study of cytokine function. Int J Exp Pathol (1993) 0.81
B-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM Production. Front Immunol (2016) 0.76
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56
The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene (2007) 10.08
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell (1991) 8.27
Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J (1998) 7.17
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J (1983) 5.93
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (1990) 5.63
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A (1991) 4.72
Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68
Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell (1984) 4.41
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell (1994) 4.22
The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell (1986) 3.72
Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J (1985) 3.68
The Ly-1 B cell lineage. Immunol Rev (1986) 3.59
Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci U S A (1983) 3.40
Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 3.19
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med (1997) 3.08
Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci (2001) 3.03
Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell (2001) 3.03
Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem (1983) 2.97
Modified nucleosides and bizarre 5'-termini in mouse myeloma mRNA. Nature (1975) 2.97
Deletions are associated with somatic rearrangement of immunoglobulin heavy chain genes. Cell (1980) 2.89
Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res (1986) 2.84
Nucleotide sequence of N-formyl-methionyl-transfer RNA. Nature (1968) 2.82
The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med (2000) 2.78
Somatic rearrangements forming active immunoglobulin mu genes in B and T lymphoid cell lines. Proc Natl Acad Sci U S A (1980) 2.77
Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene (1997) 2.70
Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell (1984) 2.60
Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. Proc Natl Acad Sci U S A (1980) 2.57
Pure and mixed erythroid colony formation in vitro stimulated by spleen conditioned medium with no detectable erythropoietin. Proc Natl Acad Sci U S A (1977) 2.55
Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood (1986) 2.45
The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J (1997) 2.44
A very large repeating unit of mouse DNA containing the 18S, 28S and 5.8S rRNA genes. Cell (1977) 2.42
Antigen-driven B cell differentiation in vivo. J Exp Med (1993) 2.35
Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol (1989) 2.30
Spontaneous repair of full-thickness defects of articular cartilage in a goat model. A preliminary study. J Bone Joint Surg Am (2001) 2.27
Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood (1986) 2.26
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25
Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. Nature (1985) 2.19
Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proc Natl Acad Sci U S A (1982) 2.16
Molecular characterization of single memory B cells. Nature (1991) 2.16
Transgenic models of tumor development. Science (1991) 2.16
A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J (1989) 2.13
Translation of immunoglobulin mRNAs in a wheat germ cell-free system. Mol Biol Rep (1974) 2.11
Separation of functionally distinct human granulocyte-macrophage colony-stimulating factors. Blood (1979) 2.05
Colony formation by human T lymphocytes in agar medium. Clin Exp Immunol (1977) 2.03
bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J (1990) 2.00
A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil (1999) 1.99
Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells. J Exp Med (1992) 1.98
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98
Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression. Nature (1980) 1.96
Colony formation in agar by multipotential hemopoietic cells. J Cell Physiol (1979) 1.96
Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci U S A (1998) 1.95
Sets of immunoglobulin V kappa genes homologous to ten cloned V kappa sequences: implications for the number of germline V kappa genes. J Mol Appl Genet (1981) 1.93
Developmental potential of the earliest precursor cells from the adult mouse thymus. J Exp Med (1991) 1.88
Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature (1994) 1.88
bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene (1996) 1.87
Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol (1990) 1.86
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation (1993) 1.84
Molecular cloning of seven mouse immunoglobulin kappa chain messenger ribonucleic acids. Biochemistry (1980) 1.82
Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc Natl Acad Sci U S A (1990) 1.80
Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J Virol (1988) 1.75
Intervening sequences divide the gene for the constant region of mouse immunoglobulin mu chains into segments, each encoding a domain. Proc Natl Acad Sci U S A (1980) 1.73
Cloned pairs of variable region genes for immunoglobulin heavy chains isolated from a clone library of the entire mouse genome. Proc Natl Acad Sci U S A (1979) 1.71
The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J (1998) 1.66
Drugs in salmonid aquaculture--a review. J Vet Pharmacol Ther (1997) 1.65
N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J (1989) 1.65
Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil (2005) 1.63
Direct stimulation by purified GM-CSF of the proliferation of multipotential and erythroid precursor cells. Blood (1980) 1.62
Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. EMBO J (1993) 1.61
Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for mu, alpha, gamma 1, gamma 2a, and gamma 3 chains. Biochemistry (1980) 1.60
Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line. Oncogene (1999) 1.59
Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange. EMBO J (1983) 1.57
Role of stem cell migration in initiation of mouse foetal liver haemopoiesis. Nature (1975) 1.56
The modified 5'-terminal sequences in messenger RNA of mouse myeloma cells. J Mol Biol (1975) 1.56
Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma. Cell (1985) 1.56
E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene (1993) 1.51
Nonneoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression. Blood (1989) 1.46
Electron microscopy of rapid identification of animal viruses in hematoxylin-eosin sections. Can J Comp Med (1977) 1.46
Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene. Nature (1985) 1.45
In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF. J Cell Physiol (1986) 1.44
Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses. Mol Biol Med (1987) 1.42
bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res (1988) 1.41
Organization of genes and spacers within the mouse immunoglobulin VH locus. J Mol Appl Genet (1981) 1.41
Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc Natl Acad Sci U S A (1988) 1.39
The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene (2001) 1.39
Sequence of 51 nucleotides at the 3'-end of R17 bacteriophage RNA. J Mol Biol (1972) 1.38
Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood (1994) 1.37
Monoclonal antibodies identify phenotypically and functionally distinct cell types in the bovine lymphoid system. Vet Immunol Immunopathol (1986) 1.35
STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem (1996) 1.35
Abdominal aortic aneurysm in women. J Vasc Surg (2001) 1.33
Untranslated nucleotide sequence at the 5'-end of R17 bacteriophage RNA. Nature (1970) 1.33
An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J (1990) 1.32
Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res (1994) 1.32
Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci U S A (1994) 1.32